Abstract
Angiomyolipomas, composed of thick-walled blood vessels, smooth muscle, and adipose tissue, belong to the perivascular epithelioid cell neoplasms (PEComas), a family of tumors believed to be derived from perivascular epithelioid cells which co-express smooth muscle and melanocytic markers. Although most angiomyolipomas are benign, a subset of PEComas has metastatic potential. The pathologic and clinical spectrum of these tumors continues to evolve. We sought to evaluate a subset of renal angiomyolipomas with a minimal amount of fat. We studied 48 renal angiomyolipomas in 41 patients (33 females and 8 males). Based on the amount of adipose tissue, the lesions were categorized as fat-poor, fat-average, and fat-rich lesions (<25, 25–75, and >75 % of fat, respectively). Stains for smooth muscle actin, calponin, HMB-45, melanocyte-associated antigen PNL2, estrogen, and progesterone receptor were examined. Four patients (all females) had more than one lesion, four had coexistent uterine leiomyomata, two had coexistent renomedullary interstitial tumor, and males had only single lesions. Except for one woman, all lesions were sporadic. Twenty-nine were fat-poor (60 %) lesions; 8, fat-average (17 %) lesions; and 11, fat-rich (23 %) lesions. The fat content did not correlate with tumor size: the largest fat-poor and smallest fat-rich lesions were >6 and <2 cm, respectively. All lesions stained with smooth muscle actin and HMB-45; 41 % of tumors were positive for estrogen receptor (11 females and 1 male). No patient had metastases (follow-up 2–11 years). In our series, fat content in angiomyolipoma was not associated with tumor size. Fat-poor angiomyolipomas affected predominantly women and were morphologically and radiologically distinct as mimickers of malignancy. Whether they are biologically different from conventional tumors requires further studies.
Similar content being viewed by others
References
L'Hostis H, Deminiere C, Ferriere JM, Coindre JM (1999) Renal angiomyolipoma: a clinicopathologic, immunohistochemical, and follow-up study of 46 cases. Am J Surg Pathol 23:1011–1020
Flor N, Sardanelli F, Serantoni S, Brovelli F, Cornalba GP (2006) Low-fat angiomyolipoma of the liver studied with contrast-enhanced ultrasound and multidetector computed tomography. Acta Radiol 47:543–546
Milner J, McNeil B, Alioto J, Proud K, Rubinas T, Picken M et al (2006) Fat poor renal angiomyolipoma: patient, computerized tomography and histological findings. J Urol 176:905–909
Hindman N, Ngo L, Genega EM, Melamed J, Wei J, Braza JM et al (2012) Angiomyolipoma with minimal fat: can it be differentiated from clear cell renal cell carcinoma by using standard MR techniques? Radiology 265:468–477
Lu Q, Wang W, Huang B, Li C (2012) Minimal fat renal angiomyolipoma: the initial study with contrast-enhanced ultrasonography. Ultrasound Med Biol 38:1896–1901
Koo KC, Kim WT, Ham WS, Lee JS, Ju HJ, Choi YD (2010) Trends of presentation and clinical outcome of treated renal angiomyolipoma. Yonsei Med J 51:728–734
Eble JN (1998) Angiomyolipoma of kidney. Semin Diagn Pathol 15:21–40
Gould Rothberg BE, Grooms MC, Dharnidharka VR (2006) Rapid growth of a kidney angiomyolipoma after initiation of oral contraceptive therapy. Obstet Gynecol 108:734–736
Folpe A (2002) Neoplasms with perivascular epithelioid cell differentiation (PEComas). In: CDM, Fletcher KU, Mertens F (eds) World Health Organization Classification of tumours pathology and genetics of tumours of soft tissue and bone. IARC, Lyon, pp 221–222
Hornick JL, Fletcher CD (2006) PEComa: what do we know so far? Histopathology 48:75–82
Bleeker JS, Quevedo JF, Folpe AL (2012) “Malignant” perivascular epithelioid cell neoplasm: risk stratification and treatment strategies. Sarcoma 2012:541626
Rubinas TC, Flanigan RC, Picken MM (2004) Pathologic quiz case: renal mass in an otherwise healthy man. Epithelioid angiomyolipoma. Arch Pathol Lab Med 128:e19–e20
Fine SW, Reuter VE, Epstein JI, Argani P (2006) Angiomyolipoma with epithelial cysts (AMLEC): a distinct cystic variant of angiomyolipoma. Am J Surg Pathol 30:593–599
Martignoni G, Pea M, Reghellin D, Zamboni G, Bonetti F (2007) Perivascular epithelioid cell tumor (PEComa) in the genitourinary tract. Adv Anat Pathol 14:36–41
Folpe AL, Mentzel T, Lehr HA, Fisher C, Balzer BL, Weiss SW (2005) Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature. Am J Surg Pathol 29:1558–1575
Logginidou H, Ao X, Russo I, Henske EP (2000) Frequent estrogen and progesterone receptor immunoreactivity in renal angiomyolipomas from women with pulmonary lymphangioleiomyomatosis. Chest 117:25–30
Cho NH, Shim HS, Choi YD, Kim DS (2004) Estrogen receptor is significantly associated with the epithelioid variants of renal angiomyolipoma: a clinicopathological and immunohistochemical study of 67 cases. Pathol Int 54:510–515
Wang J, Weiss LM, Hu B, Chu P, Zuppan C, Felix D et al (2004) Usefulness of immunohistochemistry in delineating renal spindle cell tumours. A retrospective study of 31 cases. Histopathology 44:462–471
Di Palma S, Giardini R (1988) Leiomyoma of the kidney. Tumori 74:489–493
Antic T, Perry KT, Harrison K, Zaytsev P, Pins M, Campbell SC et al (2006) Mixed epithelial and stromal tumor of the kidney and cystic nephroma share overlapping features: reappraisal of 15 lesions. Arch Pathol Lab Med 130:80–85
Vesoulis Z, Rahmeh T, Nelson R, Clarke R, Lu Y, Dankoff J (2003) Fine needle aspiration biopsy of primary renal synovial sarcoma. A case report. Acta Cytol 47:668–672
Moch H (2002) Renal tumors in adults: rare tumors and new tumor entities. Verh Dtsch Ges Pathol 86:40–48
Stone CH, Lee MW, Amin MB, Yaziji H, Gown AM, Ro JY et al (2001) Renal angiomyolipoma: further immunophenotypic characterization of an expanding morphologic spectrum. Arch Pathol Lab Med 125:751–758
Islam AH, Ehara T, Kato H, Hayama M, Nishizawa O (2004) Loss of calponin h1 in renal angiomyolipoma correlates with aggressive clinical behavior. Urology 64:468–473
Fetsch PA, Fetsch JF, Marincola FM, Travis W, Batts KP, Abati A (1998) Comparison of melanoma antigen recognized by T cells (MART-1) to HMB-45: additional evidence to support a common lineage for angiomyolipoma, lymphangiomyomatosis, and clear cell sugar tumor. Mod Pathol 11:699–703
Busam KJ, Jungbluth AA (1999) Melan-A, a new melanocytic differentiation marker. Adv Anat Pathol 6:12–18
Busam KJ, Kucukgol D, Sato E, Frosina D, Teruya-Feldstein J, Jungbluth AA (2005) Immunohistochemical analysis of novel monoclonal antibody PNL2 and comparison with other melanocyte differentiation markers. Am J Surg Pathol 29:400–406
Jungbluth AA, Iversen K, Coplan K, Kolb D, Stockert E, Chen YT et al (2000) T311—an anti-tyrosinase monoclonal antibody for the detection of melanocytic lesions in paraffin embedded tissues. Pathol Res Pract 196:235–242
Zavala-Pompa A, Folpe AL, Jimenez RE, Lim SD, Cohen C, Eble JN et al (2001) Immunohistochemical study of microphthalmia transcription factor and tyrosinase in angiomyolipoma of the kidney, renal cell carcinoma, and renal and retroperitoneal sarcomas: comparative evaluation with traditional diagnostic markers. Am J Surg Pathol 25:65–70
Panizo ASI, Idoate M, Pardo J (eds) (2006) Angiomyolipoma (AML) and perivascular epithelioid cell neoplasms (PECOMAS) are frequently immunoreactive for TFE3. XXVI Congress of the IAP, Montreal
Argani P, Ladanyi M (2005) Translocation carcinomas of the kidney. Clin Lab Med 25:363–378
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mehta, V., Venkataraman, G., Antic, T. et al. Renal angiomyolipoma, fat-poor variant—a clinicopathologic mimicker of malignancy. Virchows Arch 463, 41–46 (2013). https://doi.org/10.1007/s00428-013-1432-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00428-013-1432-2